Relmada Therapeutics Q4 EPS $(0.27) Misses $(0.14) Estimate
Benzinga Newsdesk 7 months ago
EarningsEarnings MissesNews
Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.14) by 92.86 percent. This is a 56.45 percent increase over losses of $(0.62) per share
Relmada Therapeutics (NASDAQ:RLMD) reported quarterly losses of $(0.27) per share which missed the analyst consensus estimate of $(0.14) by 92.86 percent. This is a 56.45 percent increase over losses of $(0.62) per share from the same period last year.